Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas--experience and meta-analysis
- PMID: 16619578
Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas--experience and meta-analysis
Abstract
Background: Recommendations on the use of I-123 metaiodobenzylguanidine (MIBG) scintigraphy in localising phaeochromocytomas vary. The accuracy of I-123 MIBG scintigraphy was determined by evaluating our own I-123 MIBG scans and performing a meta-analysis.
Materials and methods: Between January 1992 and May 2002, the I-123 MIBG scans of consecutive patients suspected of a phaeochromocytoma were re-evaluated. For the meta-analysis, studies with more than 5 I-123 MIBG scans were selected.
Results: Thirty patients were evaluated. The sensitivity in our own population was 92% and the specificity was 100%. Twelve articles were selected for our meta-analysis. The overall sensitivity and specificity were 96% and 100%, respectively. The sensitivity and specificity for tumours in the adrenal gland was 98% for both. For tumours located outside the adrenal gland, the sensitivity was 98% and the sensitivity for malignancies was 79%.
Conclusion: 1-123 MIBG scintigraphy has an excellent sensitivity and specificity in localising phaeochromocytomas, except for malignant tumours. 1-123 MIBG scintigraphy is superior in localising tumours outside the adrenal gland.
Similar articles
-
123I-meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis.J Clin Endocrinol Metab. 2010 Jun;95(6):2596-606. doi: 10.1210/jc.2009-2604. Epub 2010 Apr 14. J Clin Endocrinol Metab. 2010. PMID: 20392867 Review.
-
123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.Clin Endocrinol (Oxf). 2008 Aug;69(2):181-8. doi: 10.1111/j.1365-2265.2008.03256.x. Epub 2008 Apr 3. Clin Endocrinol (Oxf). 2008. PMID: 18394016
-
Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?Clin Endocrinol (Oxf). 2004 Jul;61(1):102-8. doi: 10.1111/j.1365-2265.2004.02077.x. Clin Endocrinol (Oxf). 2004. PMID: 15212651
-
Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas.J Intern Med. 2001 Mar;249(3):247-51. doi: 10.1046/j.1365-2796.2001.00792.x. J Intern Med. 2001. PMID: 11285044
-
[Nuclear medicine diagnosis of pheochromocytoma].Zentralbl Chir. 1997;122(6):443-6. Zentralbl Chir. 1997. PMID: 9334110 Review. German.
Cited by
-
Multimodality Imaging Evaluation of Primary Right Atrial Paraganglioma: A Case Report and Literature Review.Front Med (Lausanne). 2022 Jun 30;9:942558. doi: 10.3389/fmed.2022.942558. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35847796 Free PMC article.
-
Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma.J Nucl Med. 2022 Jun;63(6):869-874. doi: 10.2967/jnumed.121.262797. Epub 2021 Sep 23. J Nucl Med. 2022. PMID: 34556526 Free PMC article.
-
Imaging of Pheochromocytoma and Paraganglioma.J Nucl Med. 2021 Aug 1;62(8):1033-1042. doi: 10.2967/jnumed.120.259689. J Nucl Med. 2021. PMID: 34330739 Free PMC article.
-
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.Eur J Cancer. 2021 Mar;146:56-73. doi: 10.1016/j.ejca.2021.01.008. Epub 2021 Feb 12. Eur J Cancer. 2021. PMID: 33588146 Free PMC article. Review.
-
Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas.Oncologist. 2013;18(4):391-407. doi: 10.1634/theoncologist.2012-0410. Epub 2013 Apr 10. Oncologist. 2013. PMID: 23576482 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical